Multiple Sclerosis News Today Forums › Forums › Trials and Research › Major Drivers of MS Therapy Costs in US: Profit and Competitors’ Prices, Pharma Execs Says

  • Trials and Research

    Major Drivers of MS Therapy Costs in US: Profit and Competitors’ Prices, Pharma Execs Says

    Posted by ms-news-today-moderator on December 10, 2019 at 9:22 am

    A study based on interviews with four executives in the MS field found therapy prices driven largely by others’ prices and company profit, not research. Read the full story here.

    Do these findings surprise you? Why or why not?

    replied 4 years, 4 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .